HDAC2 siRNA and HDAC5 siRNA also promoted the death of MCF7, MCF7-TamC3, and the ER+ tamoxifen-sensitive ZR-75-1 breast cancer cells (Cameron et al., 1997) (Figures 2A,B). This evidence concerns the gene HDAC5 and breast carcinoma.